Abstract

Severe, sometimes life-threatening diarrheal disease caused by Clostridium difficile is becoming more common in hospitalized patients. Oral vancomycin or metronidazole is the usual treatment. After resolution of an episode, infection recurs (probably due to relapse) in 20% to 45% of treated patients. Now, in an empirical trial involving eight women (age range, …

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call